Petragen

Cambridge, United States

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease

$3.5M raised

Nov 2022

Series A

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Petragen

How much funding has Petragen raised?

Petragen has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Where is Petragen headquartered?

Petragen is headquartered in Cambridge, United States.

What does Petragen do?

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease

What stage is Petragen at?

Petragen is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 1, 2022.

MLA

"Petragen — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/petragen. Accessed July 3, 2026.

APA

VCBacked. (2022). Petragen — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/petragen

Wikipedia (cite web)

{{cite web |title=Petragen — Funding & Investors |url=https://www.vcbacked.co/company/petragen |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 1, 2022.